Journal Club Video Module: Long-Term Efficacy and Safety of Guselkumab

RhAPPcast

Join Jessica Farrell, a clinical pharmacist at Albany Medical Center's Division of Rheumatology and faculty member at Albany College of Pharmacy and Health Sciences, as she reviews data from the Phase III DISCOVER-2 trials. These trials evaluate the long-term efficacy and safety of guselkumab in biologic-naive patients with active psoriatic arthritis.

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes, and get the latest updates.

Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada